Original news and analysis on international IP policy
Intellectual Ventures (IV) announced today that another settlement has been reached in one of its three patent infringement cases involving nine manufacturers in the semiconductor industry.
A majority of leading firms in IP-related industries are foreign-owned, according to a new report, which argues that this should change the focus of US policymakers on domestic IP protection.
At a recent conference jointly organised by the Graduate Institute of International and Development Studies (IHEID, Geneva) and the Museum of Art and History of Geneva, academics tackled the question of the preservation of culture - in its natural and cultural dimension - against the risks of globalisation.
The European Patent Office today announced that 2012 saw a new record for patent filings in the office, and equating the rise to Europe’s “innovative powers”. But while 36.5 per cent of applications came from Europe, the fastest growth was in applications from Asia, particularly China, Korea and Japan. Korean firm Samsung took top honours for most filings, the first time for an Asian company, and a Chinese company, ZTE, broke into the top 10 for the first time.
Courts in the United States are beginning to interpret a Copyright Act of 1976 provision allowing authors of protected works to terminate their rights assignments beginning this year. Intellectual property attorneys appear to differ over the importance of the recent rulings, but they agree that the battle line in termination cases between the recording industry and artists will be drawn over whether or not a piece of music was created for hire.
The United States Supreme Court recently heard oral arguments in the case opposing a US farmer to agro-industry giant Monsanto on the issue of patent exhaustion in patented seeds. Lead lawyers in the case and others offered comments on the heels of the hearing, while the Supreme Court Justices are considering the arguments and are expected to reach a decision sometime this spring.
German pharmaceutical manufacturer Bayer has announced it will appeal yesterday's ruling in India that upheld a compulsory licence on one of its drugs.
New Delhi - India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG's kidney and liver cancer drug Nexavar in the market.
Nick Ashton-Hart writes: Some of you may have noticed that the ICT sector trade association that I represent in Geneva, the Computer and Communication Industry Association (CCIA), has endorsed a bid by the world’s Least Developed Countries (LDC’s) to remove any specific deadline for full compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.
The Medicines Patent Pool has announced a ground-breaking collaboration with a private sector joint venture that it said will facilitate greater availability of critical medicines for children with HIV worldwide. The announcement caused a wave of positive reactions across the public health community, with many hoping for more in the future.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, has announced a new funding model that aims to allow for more strategic investment.
With the threat of suspension of work looming, the World Intellectual Property Organization Standing Committee of the Law of Patents (SCP) agreed to a minimal programme of work, which includes exceptions and limitations to patent rights, quality of patents, and patents and health. Delegates made significant concessions on all sides, but the Africa Group expressed particular disappointment in the limited commitment to work on the patents and health topic.